IXICO PLC
LSE:IXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BNR Udyog Ltd
BSE:530809
|
IN |
|
G
|
Guangdong Mingzhu Group Co Ltd
SSE:600382
|
CN |
|
G
|
Guinness VCT PLC
LSE:GVCT
|
UK |
|
Jantsa Jant Sanayi ve Ticaret AS
IST:JANTS.E
|
TR |
|
A
|
Aro Granite Industries Ltd
NSE:AROGRANITE
|
IN |
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
CN |
|
H
|
Huazhang Technology Holding Ltd
HKEX:1673
|
CN |
|
A
|
Apar Industries Ltd
NSE:APARINDS
|
IN |
|
S
|
Southern Fertilizer JSC
VN:SFG
|
VN |
|
Shanghai Friendess Electronic Technology Corp Ltd
SSE:688188
|
CN |
|
Catella AB
STO:CAT B
|
SE |
|
T
|
Toyo Machinery & Metal Co Ltd
TSE:6210
|
JP |
|
Naipu Mining Machinery Co Ltd
SZSE:300818
|
CN |
|
B
|
Bajaj Steel Industries Ltd
BSE:507944
|
IN |
|
ACM Research Shanghai Inc
SSE:688082
|
CN |
|
Redsun Properties Group Ltd
HKEX:1996
|
CN |
ROE
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Peer Comparison
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| UK |
|
IXICO PLC
LSE:IXI
|
6.6m GBP |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
198.1B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
137.7B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
36.5B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
296.6B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.5B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
32.2B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.3B USD |
Loading...
|
Market Distribution
| Min | -19 346.9% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 146 990.5% |
Other Profitability Ratios
IXICO PLC
Glance View
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
See Also
ROE is calculated by dividing the Net Income by the Avg Total Equity.
The current ROE for IXICO PLC is -15.6%, which is below its 3-year median of -12.4%.
Over the last 3 years, IXICO PLC’s ROE has decreased from 8.7% to -15.6%. During this period, it reached a low of -19.2% on Sep 30, 2024 and a high of 8.7% on Sep 30, 2022.
